# FDA recall D-1547-2014

> **Hospira Inc.** · Class I · drug recall initiated 2014-04-02.

## Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), For I.V. Administration, Rx Only, 20 mL vial, Contains Benzyl Alcohol, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4699-30

## Reason for recall

Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1547-2014
- **Recalling firm:** Hospira Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-04-02
- **Report date:** 2014-08-27
- **Termination date:** 2015-05-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1547-2014

## Citation

> AI Analytics. FDA recall D-1547-2014. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-1547-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*